Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through

Banlai Ruan1,2,3, Xianzhen Feng4, Xueyi Chen1,2

  • 1Medical Research Center, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, 710016 Shaanxi Province, China.

Disease Markers
|October 28, 2020
PubMed
Abstract

Insights

This study identified four key genes (CDKL2, LRFN1, STAT2, SOWAHB) that can predict patient survival in kidney renal clear cell carcinoma (KIRC). A gene expression model using these genes offers a promising tool for KIRC prognosis.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Kidney renal clear cell carcinoma (KIRC) presents significant challenges due to high recurrence and metastasis rates.
  • Despite extensive research, effective prognostic markers for KIRC remain critical for improving patient outcomes.

Purpose of the Study:

  • To identify novel gene expression signatures for predicting prognosis in kidney renal clear cell carcinoma (KIRC).
  • To develop a reliable gene-based risk model for assessing patient survival in KIRC.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) data for comprehensive analysis.
  • Employed differential expression analysis, Cox regression, WGCNA, LASSO, and survival analysis.
  • Validated prognostic accuracy using ROC curve analysis and examined clinicopathological correlations.

Main Results:

  • Identified 5,777 differentially expressed genes, with 1,853 showing statistical significance.
  • A four-gene signature (CDKL2, LRFN1, STAT2, SOWAHB) emerged as a strong predictor of KIRC patient survival.
  • High-risk scores based on these four genes correlated with unfavorable prognoses and KIRC progression.

Conclusions:

  • A gene expression model comprising CDKL2, LRFN1, STAT2, and SOWAHB shows promise for KIRC prognosis.
  • These findings may offer valuable insights for KIRC diagnosis and therapeutic strategies.